Roddy Hiram

发表

Cardiac cytokine therapy? Relevance of targeting inflammatory mediators to combat cardiac arrhythmogenic remodeling

Roddy Hiram, R. Hiram, 2021, International journal of cardiology. Heart & vasculature.

MAG-DHA, Precursor of D-Series Resolvins, Induces Powerful Resolution of Various Components of Pulmonary Hypertension Induced By Monocrotaline in Rats

É. Rousseau, C. Morin, S. Fortin, 2016 .

CALL FOR PAPERS Biomarkers in Lung Diseases: from Pathogenesis to Prediction to New Therapies Resolvin E 1 normalizes contractility, Ca 2 (cid:2) sensitivity and smooth muscle cell migration rate in TNF- (cid:3) - and IL-6-pretreated human pulmonary arteries

É. Rousseau, C. Morin, M. Sirois, 2015 .

Resolvin E1 normalizes contractility, Ca2+ sensitivity and smooth muscle cell migration rate in TNF-α- and IL-6-pretreated human pulmonary arteries.

É. Rousseau, C. Morin, M. Sirois, 2015, American journal of physiology. Lung cellular and molecular physiology.

Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases

Roddy Hiram, R. Hiram, 2022, Molecular Biology Reports.

Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease

Roddy Hiram, R. Younes, Charles-Alexandre LeBlanc, 2022, Biomolecules.

The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodeling in experimental right heart disease.

Jiening Xiao, S. Nattel, J. Tardif, 2020, Cardiovascular research.

MAG‐DPA curbs inflammatory biomarkers and pharmacological reactivity in cytokine‐triggered hyperresponsive airway models

C. Morin, M. Sirois, Roddy Hiram, 2016, Pharmacology research & perspectives.

Biomarkers in Lung Diseases : from Pathogenesis to Prediction to New Therapies Resolvin E 1 normalizes contractility , Ca 2 sensitivity and smooth muscle cell migration rate in TNF-- and IL-6-pretreated human pulmonary arteries

É. Rousseau, C. Morin, M. Sirois, 2015 .

Docosapentaenoic acid monoacylglyceride reduces inflammation and vascular remodeling in experimental pulmonary hypertension.

P. Blier, É. Rousseau, C. Morin, 2014, American journal of physiology. Heart and circulatory physiology.

Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.

C. Tranchant, S. Jaradat, B. Allen, 2022, Biochemical pharmacology.

Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.

B. Allen, N. Alrabadi, Roddy Hiram, 2020, European journal of pharmacology.

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology

S. Nattel, D. Dobrev, J. Heijman, 2022, Nature Reviews Cardiology.

Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease.

S. Nattel, J. Tardif, J. Tanguay, 2019, Journal of the American College of Cardiology.

Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling

Shao-bo Shi, Tao Liu, He Huang, 2022, Cardiovascular Diabetology.

Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling

Shao-bo Shi, Tao Liu, He Huang, 2022, Cardiovascular Diabetology.

Mechanisms and Management of Thyroid Disease and Atrial Fibrillation: Impact of Atrial Electrical Remodeling and Cardiac Fibrosis

A. Takawale, Roddy Hiram, M. Aguilar, 2022, Cells.

Pulmonary Disease, Pulmonary Hypertension and Atrial Fibrillation.

S. Provencher, Roddy Hiram, R. Hiram, 2021, Cardiac electrophysiology clinics.

Comparison of Atrial Remodeling Caused by Sustained Atrial Flutter Versus Atrial Fibrillation.

S. Nattel, J. Tardif, R. Cartier, 2020, Journal of the American College of Cardiology.

Role of atrial arrhythmia and ventricular response in atrial fibrillation induced atrial remodeling.

Jiening Xiao, S. Nattel, J. Tardif, 2020, Cardiovascular research.

Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery.

É. Rousseau, C. Morin, M. Sirois, 2014, American journal of physiology. Heart and circulatory physiology.

Inhibition of transglutaminase 2 (TG2) ameliorates ventricular fibrosis in isoproterenol-induced heart failure in rats.

K. Alzoubi, Y. Altuntaş, C. Tranchant, 2023, Life sciences.

Involvement and possible role of transglutaminases 1 and 2 in mediating fibrotic signalling, collagen cross-linking and cell proliferation in neonatal rat ventricular fibroblasts

C. Tranchant, S. Jaradat, B. Al-Husein, 2023, PloS one.

MAG‐DPA curbs inflammatory biomarkers and pharmacological reactivity in cytokine‐triggered hyperresponsive airway models

É. Rousseau, C. Morin, M. Sirois, 2016, Pharmacology research & perspectives.

Pollutants, including Organophosphorus and Organochloride Pesticides, May Increase the Risk of Cardiac Remodeling and Atrial Fibrillation: A Narrative Review

Roddy Hiram, Doa'a G F Al-U'datt, Ewen Le Quilliec, 2023, Biomedicines.

Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery.

É. Rousseau, C. Morin, M. Sirois, 2014, American Journal of Physiology. Heart and Circulatory Physiology.